Haitang Yang
-
- Lung Cancer Treatments and Mutations 19
- Lung Cancer Diagnosis and Treatment 17
- Occupational and environmental lung diseases 11
- Ferroptosis and cancer prognosis 6
- Oncology top 5%
- Lung Cancer Research Studies 15
- Cancer Immunotherapy and Biomarkers 10
- Cancer Research top 10%
-
- RNA modifications and cancer 9
- Physiology top 10%
-
- Neuroendocrine Tumor Research Advances 7
- Co-authors
- Feng YaoRen‐Wang PengRalph A. SchmidShun‐Qing LiangSean R. R. HallThomas M. MartiHeng ZhaoDuo Xu
- Partner nations
- ChinaSwitzerlandUnited States
In The Last Decade
Haitang Yang
77 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 89
- Pulmonary and Respiratory Medicine 849
- Oncology 638
- Cancer Research 225
- Molecular Biology 622
- Physiology 35
Countries citing papers authored by Haitang Yang
This map shows the geographic impact of Haitang Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haitang Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haitang Yang more than expected).
Fields of papers citing papers by Haitang Yang
This network shows the impact of papers produced by Haitang Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haitang Yang. The network helps show where Haitang Yang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Haitang Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 5 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 10 | |
| 7 | 2024 | 5 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 13 | |
| 10 | 2021 | 47 | |
| 11 | 2021 | 28 | |
| 12 | 2021 | 22 | |
| 13 | 2020 | 36 | |
| 14 | 2020 | 29 | |
| 15 | 2020 | 14 | |
| 16 | 2019 | 29 | |
| 17 | 2019 | 31 | |
| 18 | 2019 | 33 | |
| 19 | 2018 | 45 | |
| 20 | 2017 | 3 |
About Haitang Yang
Haitang Yang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Biotechnology, having authored 82 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (19 papers), Lung Cancer Diagnosis and Treatment (17 papers), Lung Cancer Research Studies (15 papers), Occupational and environmental lung diseases (11 papers), Cancer Immunotherapy and Biomarkers (10 papers), RNA modifications and cancer (9 papers), Neuroendocrine Tumor Research Advances (7 papers) and Ferroptosis and cancer prognosis (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (849 citations), Oncology (638 citations) and Cancer Research (225 citations). Haitang Yang has collaborated with scholars based in China, Switzerland and United States. Frequent co-authors include Feng Yao, Ren‐Wang Peng, Ralph A. Schmid, Shun‐Qing Liang, Sean R. R. Hall, Thomas M. Marti, Heng Zhao, Duo Xu, Jianlin Xu and Heng Zhao.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.